Foster & Motley Inc Pfizer Inc Transaction History

Foster & Motley Inc

  • $1.46 Billion
  • Q2 2024

A detailed history of Foster & Motley Inc transactions in Pfizer Inc stock. As of the latest transaction made, Foster & Motley Inc holds 158,048 shares of PFE stock, worth $4.69 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
158,048
Previous 167,479 5.63%
Holding current value
$4.69 Million
Previous $4.65 Million 4.86%
% of portfolio
0.3%
Previous 0.32%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024
SELL
$25.26 - $29.6 $238,227 - $279,157
-9,431 Reduced 5.63%
158,048 $4.42 Million
Q1 2024

Apr 18, 2024
SELL
$25.89 - $29.73 $519,741 - $596,829
-20,075 Reduced 10.7%
167,479 $4.65 Million
Q4 2023

Feb 01, 2024
SELL
$26.13 - $33.94 $255,995 - $332,510
-9,797 Reduced 4.96%
187,554 $5.4 Million
Q3 2023

Oct 24, 2023
SELL
$32.09 - $37.51 $374,907 - $438,229
-11,683 Reduced 5.59%
197,351 $6.55 Million
Q2 2023

Aug 08, 2023
SELL
$36.12 - $41.79 $534,431 - $618,324
-14,796 Reduced 6.61%
209,034 $7.67 Million
Q1 2023

May 09, 2023
SELL
$39.39 - $51.28 $308,463 - $401,573
-7,831 Reduced 3.38%
223,830 $9.13 Million
Q4 2022

Feb 09, 2023
SELL
$41.75 - $54.5 $142,952 - $186,608
-3,424 Reduced 1.46%
231,661 $11.9 Million
Q3 2022

Nov 04, 2022
BUY
$43.76 - $53.42 $68,703 - $83,869
1,570 Added 0.67%
235,085 $10.3 Million
Q2 2022

Aug 09, 2022
SELL
$46.53 - $55.17 $101,388 - $120,215
-2,179 Reduced 0.92%
233,515 $12.2 Million
Q1 2022

Apr 28, 2022
SELL
$45.75 - $56.69 $166,209 - $205,954
-3,633 Reduced 1.52%
235,694 $12.2 Million
Q4 2021

Jan 25, 2022
SELL
$41.32 - $61.25 $382,871 - $567,542
-9,266 Reduced 3.73%
239,327 $14.1 Million
Q3 2021

Oct 29, 2021
SELL
$39.25 - $50.42 $33,990 - $43,663
-866 Reduced 0.35%
248,593 $10.7 Million
Q2 2021

Jul 20, 2021
BUY
$35.91 - $40.68 $55,947 - $63,379
1,558 Added 0.63%
249,459 $9.77 Million
Q1 2021

Apr 26, 2021
SELL
$33.49 - $37.77 $6,497 - $7,327
-194 Reduced 0.08%
247,901 $8.98 Million
Q4 2020

Feb 01, 2021
BUY
$33.47 - $42.56 $378,144 - $480,842
11,298 Added 4.77%
248,095 $9.13 Million
Q3 2020

Oct 19, 2020
SELL
$31.75 - $37.25 $273,335 - $320,685
-8,609 Reduced 3.51%
236,797 $8.69 Million
Q2 2020

Jul 20, 2020
BUY
$30.12 - $36.54 $36,535 - $44,323
1,213 Added 0.5%
245,406 $8.03 Million
Q1 2020

Apr 21, 2020
SELL
$27.03 - $38.62 $262,812 - $375,502
-9,723 Reduced 3.83%
244,193 $7.97 Million
Q4 2019

Feb 05, 2020
SELL
$32.92 - $37.36 $163,546 - $185,604
-4,968 Reduced 1.92%
253,916 $9.95 Million
Q3 2019

Oct 24, 2019
SELL
$32.49 - $42.13 $125,638 - $162,916
-3,867 Reduced 1.47%
258,884 $9.3 Million
Q2 2019

Jul 17, 2019
SELL
$36.98 - $41.52 $57,171 - $64,189
-1,546 Reduced 0.58%
262,751 $11.4 Million
Q1 2019

May 08, 2019
BUY
$37.5 - $41.2 $160,500 - $176,336
4,280 Added 1.65%
264,297 $11.2 Million
Q4 2018

Jan 30, 2019
SELL
$38.47 - $43.86 $94,136 - $107,325
-2,447 Reduced 0.93%
260,017 $11.4 Million
Q3 2018

Oct 31, 2018
SELL
$34.47 - $41.81 $198,443 - $240,700
-5,757 Reduced 2.15%
262,464 $11.6 Million
Q2 2018

Jul 24, 2018
BUY
$32.98 - $35.16 $54,581 - $58,189
1,655 Added 0.62%
268,221 $9.73 Million
Q1 2018

May 14, 2018
SELL
$31.91 - $37.02 $331,672 - $384,785
-10,394 Reduced 3.75%
266,566 $9.46 Million
Q4 2017

Jan 22, 2018
SELL
$33.26 - $35.29 $193,972 - $205,811
-5,832 Reduced 2.06%
276,960 $10 Million
Q3 2017

Oct 19, 2017
BUY
$31.0 - $34.15 $8.77 Million - $9.66 Million
282,792
282,792 $10.1 Million

Others Institutions Holding PFE

# of Institutions
3,218
Shares Held
3.71B
Call Options Held
73.2M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Foster & Motley Inc Portfolio

Follow Foster & Motley Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster & Motley Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foster & Motley Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email